DiaCelliX - new regenerative medicine product for treatment of secondary effects of T2DM
Public support
Provider
Ministry of Education, Youth and Sports
Programme
GESHER/MOST
Call for proposals
GESHER/MOST 5 (SMSM2014LJ5)
Main participants
4MEDi - Centrum buněčné terapie a diagnostiky a. s.
Contest type
VS - Public tender
Contract ID
MSMT-17996/2014-1
Alternative language
Project name in Czech
DiaCellix - produkty regenerativní medicíny pro léčbu sekundárních příznaků T2DM
Annotation in Czech
Hlavním cílem projektu je provést výzkum společného účinku stromální vaskulární frakce kmenových buněk získaných z adipózní tkáně a biomateriálů k léčbě pacientů s diabetem.
Scientific branches
R&D category
AP - Applied research
CEP classification - main branch
EI - Biotechnology and bionics
CEP - secondary branch
FP - Other medical fields
CEP - another secondary branch
FN - Epidemiology, infection diseases and clinical immunology
OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)
20801 - Environmental biotechnology<br>20802 - Bioremediation, diagnostic biotechnologies (DNA chips and biosensing devices) in environmental management<br>20803 - Environmental biotechnology related ethics<br>20901 - Industrial biotechnology<br>20902 - Bioprocessing technologies (industrial processes relying on biological agents to drive the process) biocatalysis, fermentation<br>20903 - Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials<br>30106 - Anatomy and morphology (plant science to be 1.6)<br>30107 - Medicinal chemistry<br>30108 - Toxicology<br>30109 - Pathology<br>30221 - Critical care medicine and Emergency medicine<br>30223 - Anaesthesiology<br>30224 - Radiology, nuclear medicine and medical imaging<br>30225 - Allergy<br>30226 - Rheumatology<br>30227 - Geriatrics and gerontology<br>30229 - Integrative and complementary medicine (alternative practice systems)<br>30230 - Other clinical medicine subjects<br>30302 - Epidemiology<br>30303 - Infectious Diseases<br>30307 - Nursing<br>30308 - Nutrition, Dietetics<br>30309 - Tropical medicine<br>30310 - Parasitology<br>30311 - Medical ethics<br>30312 - Substance abuse<br>30401 - Health-related biotechnology<br>30402 - Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)<br>30403 - Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions [pharmacogenomics, gene-based therapeutics])<br>30404 - Biomaterials (as related to medical implants, devices, sensors)<br>30405 - Medical biotechnology related ethics<br>30501 - Forensic science<br>30502 - Other medical science<br>40401 - Agricultural biotechnology and food biotechnology<br>40402 - GM technology (crops and livestock), livestock cloning, marker assisted selection, diagnostics (DNA chips and biosensing devices for the early/accurate detection of diseases) biomass feedstock production technologies, biopharming<br>40403 - Agricultural biotechnology related ethics
Completed project evaluation
Provider evaluation
O - Nesplněno zadání, smlouva však byla dodržena
Project results evaluation
The project did not bring the planned outputs. No final opposition has not yet been made and a final project report has not been delivered.
Solution timeline
Realization period - beginning
Aug 1, 2014
Realization period - end
Dec 31, 2016
Project status
U - Finished project
Latest support payment
Feb 17, 2016
Data delivery to CEP
Confidentiality
C - Předmět řešení projektu podléhá obchodnímu tajemství (§ 504 Občanského zákoníku), ale název projektu, cíle projektu a u ukončeného nebo zastaveného projektu zhodnocení výsledku řešení projektu (údaje P03, P04, P15, P19, P29, PN8) dodané do CEP, jsou upraveny tak, aby byly zveřejnitelné.
Data delivery code
CEP17-MSM-LJ-U/01:1
Data delivery date
Jun 23, 2017
Finance
Total approved costs
11,000 thou. CZK
Public financial support
4,950 thou. CZK
Other public sources
0 thou. CZK
Non public and foreign sources
6,050 thou. CZK